Pivotal phase III trial of darinaparsin + CHOP in patients wih peripheral T-cell lymphoma

Trial Profile

Pivotal phase III trial of darinaparsin + CHOP in patients wih peripheral T-cell lymphoma

Planning
Phase of Trial: Phase III

Latest Information Update: 17 May 2011

At a glance

  • Drugs Cyclophosphamide; Darinaparsin; Doxorubicin; Prednisone; Vincristine
  • Indications Peripheral T-cell lymphoma
  • Focus Registrational; Therapeutic Use
  • Sponsors ZIOPHARM Oncology
  • Most Recent Events

    • 17 May 2011 Planned initiation date changed to 1 Dec 2011.
    • 21 Jan 2011 Ziopharm received positive opinion for orphan drug desigination for darinaparsin for EMA, according to a Ziopharm media release
    • 29 Jan 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top